TEXT-EXTRACT 2 filename2.txt United States securities and exchange commission logo March 12, 2021 Nasrat Hakim Chief Executive Officer Elite Pharmaceuticals Inc. 165 Ludlow Avenue Northvale, New Jersey 07647 Re: Elite Pharmaceuticals Inc. Form 10-K for fiscal year ended March 31, 2020 Filed June 29, 2020 File No. 001-15697 Dear Mr. Hakim: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences